No Data
No Data
Morgan Stanley Downgrades JD Health International to Underweight From Equal-weight; Price Target Is HK$20.40
01:21 AM EDT, 07/17/2024 (MT Newswires) -- Morgan Stanley Downgrades JD Health International to Underweight From Equal-weight; Price Target is HK$20.40
JD Health (06618) granted 1.1038 million shares of incentive stock.
jd health (06618) announced that on July 1, 2024, the company will grant shares in accordance with the first public offering...
Hong Kong Shares Rebound 2.9% Amid Positive Sentiment
Hong Kong's Hang Seng Index extended early gains to close 2.9% higher at 18430.39. There could be some optimism among investors that more may be done by the Chinese authorities in 2H, IG market strate
Hang Seng Index Likely to Consolidate Between 18500-20000 Near Term
0642 GMT - Hong Kong's Hang Seng Index is likely to consolidate between 18500 and 20000 in the near term, according to CCB International analysts Cliff Zhao and Wilson Zou in a research note. They say
Market Chatter: JD.com's Healthcare Arm Shuttering Family Doctor Initiative
Chinese e-commerce giant JD.com (HKG:9618) closed its healthcare arm JD Health International's (HKG:6618) family doctor division after failing to turn a profit, Yicai Global reported Tuesday, citing a
Despite slow growth, Ali Health is gradually becoming “healthy”
Jinwu Financial News | On May 27, Alibaba Health (00241.HK) announced its annual results for the 2024 fiscal year ending March 31, 2024. During the reporting period, it achieved revenue of 27.027 billion yuan, a slight increase of 1.0% year on year, and realized net profit of 883 million yuan, an increase of 64.6% year on year, with a significant increase in profit against the backdrop of flat revenue growth. The number of members of over 77 million and a MAU of up to 300 million have made Ali Health's current earnings report very popular. Driven by the results, Alibaba Health Hong Kong stock surged 10% on the 28th.
No Data